NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
This planningUpdate stage contract from NHS England was published in 2026. The NHS NOFE and Midlands & East Branded Medicines - Tranche A- 1 September 2026 contract.
This UK government contract opportunity is part of the public procurement process, openly available via Find a Tender.
13 Mar
Published
Current
planningUpdate
Contract value not disclosed
UK tender activity (12 months)
Ask the AI assistant for deeper analysis of this scope
Important deadlines and milestones
Tender opportunity made public on Find a Tender
This is a public procurement by NHS England. All UK government contracts are publicly accessible for transparency.
This government contract is active. Look for subcontracting opportunities.
Complete your profile for personalized match scoring
Analyze how well this tender matches your company profile and capabilities.
UK tender activity (12 months)
ocds-h6vhtk-051c98RFP.quest helps UK businesses find and win public sector tenders. Our AI platform analyzes requirements, identifies gaps, and helps craft winning proposals.
AI-powered bid management
UK procurement tools
Expert guidance
Step-by-step guide
UK tender data from Find a Tender under the Open Government Licence. Powered by RFP.quest.
I can help you understand this NHS England contract:
• Requirements and evaluation criteria • Risks and gaps analysis • Buyer and market context • Related opportunities
Ask me anything about "NHS NOFE and Midlands & East Branded Medicines - Tranche A- 1 September 2026"!
Powered by CopilotKit